Peripheral T-cell lymphoma

Common Name(s)

Peripheral T-cell lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Peripheral T-cell lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Peripheral T-cell lymphoma" returned 246 free, full-text research articles on human participants. First 3 results:

Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation.
 

Author(s): Luis F Porrata, David J Inwards, Stephen M Ansell, Ivana N Micallef, Patrick B Johnston, William J Hogan, Svetomir N Markovic

Journal:

 

The infused autograft lymphocyte-to-monocyte ratio (A-LMR) is a prognostic factor for survival in B-cell lymphomas post-autologous peripheral hematopoietic stem cell transplantation (APHSCT). Thus, we set out to investigate if the A-LMR is also a prognostic factor for survival post-APHSCT ...

Last Updated: 3 Jul 2015

Go To URL
Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.
 

Author(s): Sung-Hoon Jung, Jae-Sook Ahn, Yeo-Kyeoung Kim, Sun-Seog Kweon, Jung-Joon Min, Hee-Seung Bom, Hyeoung-Joon Kim, Yee Soo Chae, Joon Ho Moon, Sang Kyun Sohn, Sang Woo Lee, Byung Hyun Byun, Young Rok Do, Je-Jung Lee, Deok-Hwan Yang

Journal:

 

The role of interim PET/CT in peripheral T-cell lymphoma (PTCL) is less identified compared to other subtype of lymphoma. This study prospectively investigated the prognostic accuracy of sequential interim PET/CT using visual and quantitative assessment to determine whether it provided ...

Last Updated: 17 Apr 2015

Go To URL
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.
 

Author(s): Rebecca L Boddicker, N Sertac Kip, Xiaoming Xing, Yu Zeng, Zhi-Zhang Yang, Jeong-Heon Lee, Luciana L Almada, Sherine F Elsawa, Ryan A Knudson, Mark E Law, Rhett P Ketterling, Julie M Cunningham, Yanhong Wu, Matthew J Maurer, Megan M O'Byrne, James R Cerhan, Susan L Slager, Brian K Link, Julie C Porcher, Deanna M Grote, Diane F Jelinek, Ahmet Dogan, Stephen M Ansell, Martin E Fernandez-Zapico, Andrew L Feldman

Journal: Blood. 2015 May;125(20):3118-27.

 

Peripheral T-cell lymphomas (PTCLs) are generally aggressive non-Hodgkin lymphomas with poor overall survival rates following standard therapy. One-third of PTCLs express interferon regulatory factor-4 (IRF4), a tightly regulated transcription factor involved in lymphocyte growth ...

Last Updated: 15 May 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Peripheral T-cell lymphoma" returned 20 free, full-text review articles on human participants. First 3 results:

Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray.
 

Author(s): Matthew A Lunning

Journal: Oncology (Williston Park, N.Y.). 2015 Aug;29(8):545-50.

 

Previously obscured within other designations of aggressive lymphomas, peripheral T-cell lymphoma (PTCL) now represents 23 different subtypes of non-Hodgkin lymphoma (NHL). Despite the many subtypes now recognized, PTCL represents only approximately 10% of all NHL cases diagnosed. ...

Last Updated: 18 Aug 2015

Go To URL
The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
 

Author(s): Nozomi Niitsu

Journal: J Clin Exp Hematop. 2014 ;54(3):171-7.

 

nm23-H1 was originally identified as a protein that is expressed at a lower than usual level in metastatic cancer cells. The nm23 genes play critical roles in cellular proliferation, differentiation, oncogenesis, and tumor metastasis. Peripheral T-cell lymphoma (PTCL) is relatively ...

Last Updated: 16 Dec 2014

Go To URL
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
 

Author(s): Owen A O'Connor, Govind Bhagat, Karthik Ganapathi, Martin Bjerregaard Pedersen, Francesco D'Amore, Dejan Radeski, Susan E Bates

Journal: Clin. Cancer Res.. 2014 Oct;20(20):5240-54.

 

Despite enormous advances in our understanding of aggressive lymphomas, it is clear that progress in the peripheral T-cell lymphomas (PTCL) has lagged well behind other B-cell malignancies. Although there are many reasons for this, the one commonly cited notes that the paradigms for ...

Last Updated: 16 Oct 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
 

Status: Recruiting

Condition Summary: Relapsed Peripheral T-Cell Lymphoma; Refractory Peripheral T-Cell Lymphoma

 

Last Updated: 10 Feb 2016

Go to URL
Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study
 

Status: Recruiting

Condition Summary: Peripheral T-cell Lymphomas (PTCL); Peripheral T-cell Lymphomas Not Otherwise Specified (PTCL-NOS),; Angioimmunoblastic T-cell Lymphoma (AITL); ALK- Anaplastic Largecell Lymphoma (ALCL).

 

Last Updated: 14 Aug 2015

Go to URL
Treatment of Peripheral T-cell Lymphoma
 

Status: Recruiting

Condition Summary: Peripheral T-cell Lymphoma

 

Last Updated: 15 Jul 2015

Go to URL